Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Singular Genomics Systems, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 69 | 2 | 76 | +9 |
| Shares | 41.0M | 35.4K | 39.0M | −1.97M (−4.8%) |
| Value | $258.7M | $223.0K | $149.1M | −$109.4M (−42.3%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Singular Genomics Systems, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Oasis Management Co Ltd. | 221,729 | $847.0K | 0.15% |
| Two Sigma Advisers, LP | 77,300 | $295.0K | 0.00% |
| Prelude Capital Management, LLC | 31,550 | $121.0K | 0.01% |
| Voya Investment Management LLC | 20,937 | $80.0K | 0.00% |
| SG Americas Securities, LLC | 20,921 | $80.0K | 0.00% |
| Invesco Ltd. | 16,161 | $62.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 15,228 | $58.0K | 0.00% |
| Bay Rivers Group | 14,000 | $53.0K | 0.05% |
| Bridgeway Capital Management, LLC | 13,500 | $52.0K | 0.00% |
| AQR Capital Management LLC | 10,327 | $39.0K | 0.00% |
| Marino, Stram & Associates LLC | 10,000 | $38.0K | 0.01% |
| Nisa Investment Advisors, LLC | 5,200 | $20.0K | 0.00% |
| Cannell Capital LLC | 3,014 | $12.0K | 0.00% |
| Clearstead Advisors, LLC | 1,500 | $6.00K | 0.00% |
| Credit Suisse AG | 52 | $0 | 0.00% |
Sold out (6)
Institutions that held Singular Genomics Systems, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Nicholas Investment Partners, LP | 519,885 | $3.28M |
| Cinctive Capital Management LP | 91,303 | $576.0K |
| Marshall Wace, LLP | 17,459 | $111.0K |
| Point72 Hong Kong Ltd | 1,895 | $12.0K |
| Quantbot Technologies LP | 1,245 | $7.00K |
| State of Wyoming | 130 | $1.00K |
Not filed for Q2 2022 yet (2)
Institutions that held Singular Genomics Systems, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 31,530 | $199.0K |
| Amalgamated Financial Corp. | 3,833 | $24.0K |